Jane Thompson is Head of U.S. Market Access for UCB, overseeing the Market Access Strategy, Account Management, Channel and Trade Relations, Field Access and Reimbursement, and Health Outcomes, Value and Access Strategy teams.

At UCB, we come together every day to work, laser-focused, on a simple question: How will we create value for people living with severe diseases? Jane is responsible for and plays a pivotal role across the Market Access continuum including evidence generation, strategic insights, and execution. Her strategic approach to create innovative, customized approaches for external stakeholders across the healthcare continuum to enable optimal access for patients. She serves as a member of both the U.S. Leadership Team, APEX Global Access Leadership Team, Board member of UPAC and serves as co-chair for PCMA Diversity Leadership.

Prior to joining UCB, Jane held various U.S. Market Access Leadership roles for Teva Pharmaceuticals. She has expertise in account management and market access in biologics, biosimilars and generic medicines. Further, Jane has a focused history in leading commercial, government, specialty pharmacy, reimbursement, and trade organizations.

Download Bio